polymeric nanoparticles in drug delivery : overcoming barriers to reach the market
DESCRIPTION
Polymeric nanoparticles in drug delivery : overcoming barriers to reach the market. A drug d elivery c ompany. Polymeric nanoparticles. Business model. Nanomedicine Clinical Investigations. Commercial Nanomedicine Products. Nanomedicine application in development. Licensing. - PowerPoint PPT PresentationTRANSCRIPT
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
1
Polymeric nanoparticles in drug delivery: overcoming
barriers to reach the market
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
2
A drug delivery company
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
3
Polymeric nanoparticles
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
4
Business model
Basic Nanoscience Research
Application Development
Preclinical Studies Clinical Studies Commercial Product
Nanomedicine application in development
Nanomedicine Clinical Investigations
Commercial Nanomedicine Products
LABORATORY MARKET
Licensing
Co-development
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
5
Key points to overcome the barrier
EFFICACY AND
SAFETY
COMPETITIVE ADVANTAGE
INTELLECTUAL PROPERTY
REGULATORY ISSUES
SCALE-UP AND PRICE
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
6
Polymeric nanotechnology for drug delivery
Superior product benefit
Increased bioavailability
Controlled release
Enhanced solubility
Robust stability profile
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
7
Favorable conditions for collaboration
Intellectual property rights until 2032
PCT/EP2012/056900Nanoparticles comprising esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof
PCT/EP2013/052795Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
8
Smooth regulatory pathway
All excipients are GRAS listed
Very well known excipients: water, ethanol , propylene glycol...
Widely used in a diverse range of pharmaceutical formulations
GRAS: Generally Recognized as Safe
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
9
Easy and cost-effective production
No volatile organic solventsAvoids the use of special equipment and techniques
Production using standard processes of solution preparation
Low cost of goods ensures excellent profit margin
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
10
Successful case 1: minoxidil
Minoxidil Hair Loss
Treatment
Irritant excipient
Patent protected
Easy development
Low price
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
11
Successful case 1: minoxidil
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
12
Successful case 2: mucosal vaccination
Nano-vaccine for aquiculture
No marketed product
Vaccination by
immersion bath
Suitable for food use
Patent protected
Low price
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
13
Successful case 2: mucosal vaccination
Mucosal immunization with antigens-loaded nanoparticles induces long lasting immunity
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
14
To take home
VIII Jornadas de Aplicaciones Industriales de la Nanotecnología
15
Contact details
• Controlled releasing of molecules
• Enhancing of residence time
• Drug targeting
• Drug isolation from incompatible excipients
• Increasing bioavailability of hydrophobic or hydrophilic molecules
• Improving stability
• Increasing drug solubility
• PK modification
LET US HELP YOU IN…
Ricardo Palacios, PhD, MBABusiness Development Director
www.bionanoplus.com Plaza Ceín, 5 Nave 14B | Polígono industrial
Mocholí31110 Noaín – Navarra | SPAIN